Studies of spinal cord tissue from ALS patients have identified the upregulation of genes such as TREM2, TYROBP, APOE, CD33, and MS4A, while markers like TMEM119 remain unchanged [24]. This evidence concerns the gene CD33 and amyotrophic lateral sclerosis.